Meglumine sodium succinate for diabetic ketoacidosis

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 1 May 2025: Trial started, NCT06955416
  2. 2 May 2025: Trial registered, NCT06955416

The trials

NCT06955416: REAMBERIN® 1.5% in Rehydration Therapy of Diabetic Ketoacidosis

State
Under way
Phase
Phase 2 and Phase 3
People
312 planned
Started
1 May 2025
Primary completion
1 Dec 2027
Arms
Reamberin
Results
None posted
  1. 1 May 2025: Trial started
  2. 2 May 2025: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

About the treatment

Kind of treatment: Drug.

Also known as Reamberin.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.